Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC

• 主要な著者: Weijie Ma (著者), Jie Zeng (著者), Shuai Chen (著者), Yue Lyu (著者), Kyra A. Toomey (著者), Chinh T. Phan (著者), Ken Y. Yoneda (著者), Tianhong Li (著者)
• フォーマット: 図書
• 出版事項: BMC, 2021-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Lack of biomarkers and in vitro models has contributed to inadequate understanding of the mechanisms underlying the inferior clinical response to immune checkpoint inhibitors (ICIs) in patients with oncogene-driven non-small cell lung cancer (NSCLC). Methods The effect of small m...